ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.

Company profile
Ticker
RMD, RSMDF
Exchange
Website
CEO
Michael Farrell
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Haemonetics • Hill-Rom • Nuvasive • Integra Lifesciences ...
SEC CIK
Corporate docs
Subsidiaries
ResMed Corp. • ResMed (UK) Ltd • ResMed Asia Pacific Ltd • ResMed Beteiligungs GmbH • ResMed Holdings Pty Ltd • ResMed Pty Ltd • ResMed GmbH and Co • ResMed Motor Technologies Inc. • ResMed SAS • ResMed Paris SAS ...
IRS number
980152841
RMD stock data
News

Competitor Recall Continues To Show Opportunities For ResMed
12 Aug 22
JP Morgan Downgrades ResMed to Neutral
12 Aug 22
Tuesday Is Your Last Chance To Buy ResMed Before The Dividend Payout
12 Aug 22
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
12 Aug 22
RBC Capital Downgrades ResMed to Sector Perform, Raises Price Target to $252
12 Aug 22
Press releases
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022
11 Aug 22
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
3 Aug 22
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
2 Aug 22
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
14 Jul 22
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating ResMed Inc.
29 Jun 22
Analyst ratings and price targets
Calendar
11 Aug 22
19 Aug 22
30 Jun 23
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 273.71M | 273.71M | 273.71M | 273.71M | 273.71M | 273.71M |
Cash burn (monthly) | (no burn) | 1.8M | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 3.02M | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 270.69M | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 150.6 | n/a | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Aug 22 | Farrell Michael J. | ResMed Common Stock | Sell | Dispose S | No | Yes | 238.0909 | 5,675 | 1.35M | 405,260 |
15 Aug 22 | Farrell Michael J. | ResMed Common Stock | Option exercise | Acquire M | No | Yes | 57.76 | 5,675 | 327.79K | 410,935 |
15 Aug 22 | Farrell Michael J. | ResMed Common Stock Options ResMed Common Stock | Option exercise | Dispose M | No | No | 57.76 | 5,675 | 327.79K | 88,590 |
10 Aug 22 | Sandercock Brett | ResMed Common Stock | Sell | Dispose S | No | Yes | 240.66 | 2,500 | 601.65K | 106,426 |
10 Aug 22 | Sandercock Brett | ResMed Common Stock | Option exercise | Acquire M | No | Yes | 57.76 | 2,500 | 144.4K | 108,926 |
10 Aug 22 | Sandercock Brett | ResMed Common Stock Options ResMed Common Stock | Option exercise | Dispose M | No | No | 57.76 | 2,500 | 144.4K | 0 |
3 Aug 22 | David Pendarvis | ResMed Common Stock | Sell | Dispose S | No | Yes | 240.72 | 1,545 | 371.91K | 105,286 |
22 Jul 22 | Sandercock Brett | ResMed Common Stock | Sell | Dispose S | No | Yes | 235 | 7,500 | 1.76M | 106,426 |
22 Jul 22 | Sandercock Brett | ResMed Common Stock | Option exercise | Acquire M | No | Yes | 57.76 | 2,500 | 144.4K | 113,926 |
22 Jul 22 | Sandercock Brett | ResMed Common Stock | Option exercise | Acquire M | No | Yes | 57.76 | 2,500 | 144.4K | 111,426 |
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0 |
Total shares | 0 |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Financial report summary
?Risks
- Risks Related to Our Business and Industry
- Risks Related to Manufacturing, IT Systems, Commercial Operations and Plans for Future Growth
- Risks Related to Non-Compliance with Laws, Regulations and Healthcare Industry Shifts
- Risks Related to the Securities Markets and Ownership of Our Common Stock
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
actigraphy, acuity, adjacent, adjournment, admission, AI, AIS, alleged, amplified, answered, appeal, artificial, backlog, Bloomington, CA, CalAmp, candidate, capture, CFC, CHEST, Cleveland, clicking, coinsurance, Colorado, complaint, conflict, constraint, cut, cyberattack, DAN, Dec, Deutschland, DIS, ease, ecosystem, emphasizing, English, enjoy, entrant, Environmental, ERS, escalation, ESG, EUDAMED, expressly, Fargo, FCPA, forty, greenhouse, guiding, Halifax, hearing, highest, HSBC, ID, inbound, inflationary, injunction, inorganic, intelligence, intelligent, ITC, IVDR, Jun, Koninklijke, Laird, LTE, malware, mandatory, manual, MDD, MEDIFOX, merchandise, military, mind, mined, Minnesota, moratorium, motion, newest, NightOwl, North, NYU, official, outpatient, paper, partly, partner, PAT, PAYGO, peace, peripheral, permissibility, philosophy, PLC, preexisting, presumption, proportion, Quectel, ransomware, rebuttable, recession, reclassified, reopen, RS, Russia, sequestration, session, situation, sought, stability, stabilizing, stakeholder, Telit, theme, thereto, threat, threaten, timeframe, trailing, UFLPA, UK, Ukraine, Unconditional, unforeseen, upfront, USA, Utah, Uyghur, VAuto, version, vertical, Virginia, visiting, wage, waiting, weather, widespread, Xinjiang, Xirgo
Removed:
adjustable, affirmative, affirmatively, Annex, arrangement, assisted, autotitration, backup, bad, Birdie, bundled, CS, defending, directing, earliest, elimination, exhibiting, exit, extra, featuring, finance, forma, HCF, Holdco, hypoxemic, improper, Inova, inquiring, leak, LIBOR, Loyang, LTOT, mark, mixed, nocturnal, occurred, pro, projection, prospectively, pseudonymised, purpose, rationalization, reading, Reciprocal, regime, relocation, reorganization, resting, resupply, retained, retrospective, ruled, Shield, smaller, ST, synchrony, tentative, tick, ultimately, unaudited, upheld, ventilated, web
Financial reports
Current reports
8-K/A
Regulation FD Disclosure
11 Aug 22
8-K
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022
11 Aug 22
8-K
Departure of Directors or Certain Officers
1 Jul 22
8-K
Entry into a Material Definitive Agreement
30 Jun 22
8-K
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software
14 Jun 22
8-K
ResMed Announces Leadership Change
11 May 22
8-K
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
28 Apr 22
8-K
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
27 Jan 22
8-K
Submission of Matters to a Vote of Security Holders
19 Nov 21
8-K
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022
28 Oct 21
Registration and prospectus
S-8
Registration of securities for employees
21 May 21
S-8
Registration of securities for employees
13 Aug 20
S-8
Registration of securities for employees
30 Apr 18
S-8
Registration of securities for employees
27 Feb 14
S-8
Registration of securities for employees
31 Jan 13
S-8
Registration of securities for employees
9 May 12
S-8
Registration of securities for employees
27 May 10
S-8
Registration of securities for employees
25 Jan 10
S-8
Registration of securities for employees
10 Dec 08
S-8
Registration of securities for employees
30 Jan 07
Proxies
DEFA14A
Additional proxy soliciting materials
6 Oct 21
DEFA14A
Additional proxy soliciting materials
6 Oct 20
DEFA14A
Additional proxy soliciting materials
8 Oct 19
DEFR14A
Revised proxy
30 Oct 18
DEFA14A
Additional proxy soliciting materials
3 Oct 18
DEF 14A
Definitive proxy
3 Oct 18
DEFA14A
Additional proxy soliciting materials
25 Sep 17
Other
SD
Conflict minerals disclosure
25 May 22
SD
Conflict minerals disclosure
26 May 21
UPLOAD
Letter from SEC
15 Apr 21
CORRESP
Correspondence with SEC
28 Mar 21
UPLOAD
Letter from SEC
25 Feb 21
SD
Conflict minerals disclosure
22 May 20
SD
Conflict minerals disclosure
22 May 19
SD
Conflict minerals disclosure
29 May 18
SD
Conflict minerals disclosure
23 May 17
UPLOAD
Letter from SEC
16 Jan 17
Ownership
5
RESMED / RICHARD SULPIZIO ownership change
18 Aug 22
5
RESMED / James Hollingshead ownership change
17 Aug 22
4
RESMED / Michael J. Farrell ownership change
17 Aug 22
4
RESMED / Brett Sandercock ownership change
12 Aug 22
4
RESMED / DAVID PENDARVIS ownership change
4 Aug 22
4
RESMED / Brett Sandercock ownership change
26 Jul 22
4
RESMED / Michael J. Farrell ownership change
18 Jul 22
3
RESMED / LUCILE BLAISE ownership change
15 Jul 22
4
RESMED / DAVID PENDARVIS ownership change
6 Jul 22
4
RESMED / Michael J. Farrell ownership change
16 Jun 22
Patents
Utility
Respiratory Pressure Therapy System
18 Aug 22
Apparatus and methods provide compliance management tools such as for respiratory pressure therapy.
Utility
Patient Interface
18 Aug 22
A seal-forming structure for a patient interface may include a patient-contacting surface configured to engage the patient's facial skin to form a seal; a posterior opening formed in the patient-contacting surface, the posterior opening configured to provide the flow of air at said therapeutic pressure to the patient's nares; and a support structure extending from the patient contacting surface to an interior surface of the seal-forming structure, the support structure and the interior surface forming a continuous loop, wherein the patient interface is configured to allow the patient to breath from ambient through their mouth in the absence of a flow of pressurised air through the plenum chamber inlet port, or the patient interface is configured to leave the patient's mouth uncovered.
Utility
Breathable gas supply apparatus
16 Aug 22
A CPAP device for delivering pressurized, humidified breathable gas for a patient includes a flow generator configured to pressurize a flow of breathable gas.
Utility
Patient interface
16 Aug 22
A seal-forming structure for a patient interface may include a patient-contacting surface configured to engage the patient's facial skin to form a seal; a posterior opening formed in the patient-contacting surface, the posterior opening configured to provide the flow of air at said therapeutic pressure to the patient's nares; and a support structure extending from the patient contacting surface to an interior surface of the seal-forming structure, the support structure and the interior surface forming a continuous loop, wherein the patient interface is configured to allow the patient to breath from ambient through their mouth in the absence of a flow of pressurised air through the plenum chamber inlet port, or the patient interface is configured to leave the patient's mouth uncovered.
Utility
Adjustable Headgear That Is Easy to Don and Doff
11 Aug 22
A patient interface includes a plenum chamber, a seal-forming structure, and a positioning and stabilising structure to provide a force to hold the seal-forming structure in a therapeutically effective position on a patient's head.
Transcripts
2022 Q4
Earnings call transcript
12 Aug 22
2022 Q3
Earnings call transcript
29 Apr 22
2022 Q2
Earnings call transcript
28 Jan 22
2022 Q1
Earnings call transcript
29 Oct 21
2021 Q4
Earnings call transcript
6 Aug 21
2021 Q3
Earnings call transcript
30 Apr 21
2021 Q2
Earnings call transcript
29 Jan 21
2020 Q1
Earnings call transcript
29 Oct 20
2020 Q4
Earnings call transcript
5 Aug 20
2020 Q3
Earnings call transcript
30 Apr 20
Reddit threads
Suspect I will have overcontributed to my Roth IRA this year but the account is currently losing money
17 Aug 22
Daily Discussion Thread - August 17th, 2022
17 Aug 22
Daily Discussion Thread - August 16th, 2022
16 Aug 22
I don't understand ROTH IRA
11 Aug 22
Is there any point to contribute to an IRA with a single income greater than $78k?
11 Aug 22
How crazy is the advisory industry? Let me tell you.
11 Aug 22
Daily Discussion Thread - August 11th, 2022
11 Aug 22
Daily Discussion Thread - August 10th, 2022
10 Aug 22
Best Type of Account For Living On Dividend Income?
4 Aug 22
Thoughts on my plans?
2 Aug 22